C. M. Karner and F. Long, Wnt signaling and cellular metabolism in osteoblasts, Cell Mol. Life Sci, vol.74, issue.9, pp.1649-1657, 2017.

C. Wan, Role of HIF-1alpha in skeletal development, Ann. N. Y. Acad. Sci, vol.1192, pp.322-328, 2010.

A. Grüneboom, A network of trans-cortical capillaries as mainstay for blood circulation in long bones, Nat. Metab, vol.1, issue.2, pp.236-250, 2019.

Y. Wang, The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development, J. Clin. Invest, vol.117, issue.6, pp.1616-1642, 2007.

C. Wan, Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration, Proc. Natl Acad. Sci. USA, vol.105, issue.2, pp.686-91, 2008.

J. N. Regan, Up-regulation of glycolytic metabolism is required for HIF1alpha-driven bone formation, Proc. Natl Acad. Sci. USA, vol.111, issue.23, pp.8673-8681, 2014.

E. Esen, WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation, Cell Metab, vol.17, issue.5, pp.745-55, 2013.

G. Adamek, Fatty acid oxidation in bone tissue and bone cells in culture. Charact. hormonal influences, Biochem. J, vol.248, issue.1, pp.129-166, 1987.

A. Niemeier, Uptake of postprandial lipoproteins into bone in vivo: impact on osteoblast function, Bone, vol.43, issue.2, pp.230-237, 2008.

C. T. Chen, Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells, Stem Cell, vol.26, issue.4, pp.960-968, 2008.

S. V. Komarova, F. I. Ataullakhanov, and R. K. Globus, Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts, Am. J. Physiol. Cell Physiol, vol.279, issue.4, pp.1220-1229, 2000.

J. Wei, Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation, Cell, vol.161, issue.7, pp.1576-1591, 2015.

M. Skrtic, Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia, Cancer Cell, vol.20, issue.5, pp.674-88, 2011.

C. Scholtysek, PPARbeta/delta governs Wnt signaling and bone turnover, Nat. Med, vol.19, issue.5, pp.608-621, 2013.

N. Ipseiz, Adopted orphans as regulators of inflammation, immunity and skeletal homeostasis, Swiss Med. Wkly, vol.144, p.14055, 2014.

G. D. Barish, V. A. Narkar, and R. M. Evans, PPAR delta: a dagger in the heart of the metabolic syndrome, J. Clin. Invest, vol.116, issue.3, pp.590-597, 2006.

H. Fu, Impaired musculoskeletal response to age and exercise in PPARbeta(-/-) diabetic mice, Endocrinology, vol.155, issue.12, pp.4686-96, 2014.

A. Kleyer, Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss, J. Bone Min. Res, vol.27, issue.12, pp.2442-51, 2012.

C. Bouffi, IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis, PLoS One, vol.5, issue.12, p.14247, 2010.

M. Dominici, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, issue.4, pp.315-322, 2006.

G. Kronke, R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway, Arthritis Rheum, vol.62, issue.8, pp.2303-2315, 2010.